RE:RE:Good newsJTP, this is a very good news release because the company is now validating with consistency that the diagnostic protocals work!
Unfortunately, this is a service for hire by partnership or licensing or some other method. So, even thought the tech itself is revolutionary, until a serious partner appears to put it into play in the real world of medicine, it will languish.
This company is a serious target for big pharma acquisition.